PEN
Penumbra IncCompany Information
- Company Name
- Penumbra Inc
- CIK
- CIK0001321732
- Category
- Large accelerated filer
- Ticker: Exchange
- PEN: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- PEN
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-04-02
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 264,820
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 33,516,964
- Shares outstanding
- 39,353,965
- Ownership
- 85.17%
Earnings Market Reaction
- Filing date
- 2026-07-30
- Price on filing date
- —
- 1-month reaction
- 1.67%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 205 | 241 | 187 | 321 | 422 | 376 | 324 | 280 | 288 | 223 | 167 | 101 | ||||||
| Available For Sale Securities Debt Securities Current | 454 | 374 | 358 | 149 | 3 | 3 | 16 | 11 | 51 | 90 | 122 | 148 | ||||||
| Accounts Receivable Net Current | 190 | 183 | 190 | 183 | 176 | 168 | 168 | 176 | 201 | 192 | 202 | 207 | ||||||
| Inventory Net | 443 | 439 | 432 | 432 | 428 | 416 | 407 | 393 | 374 | 398 | 388 | 374 | ||||||
| Prepaid Expense And Other Assets Current | 52 | 38 | 50 | 55 | 38 | 37 | 37 | 31 | 29 | 31 | 36 | 39 | ||||||
| Assets Current | 1,344 | 1,275 | 1,217 | 1,142 | 1,065 | 1,000 | 951 | 892 | 944 | 935 | 915 | 868 | ||||||
| Property Plant And Equipment Net | 147 | 134 | 117 | 98 | 85 | 72 | 63 | 60 | 58 | 76 | 73 | 66 | ||||||
| Operating Lease Right Of Use Asset | 167 | 170 | 174 | 171 | 174 | 175 | 178 | 181 | 183 | 186 | 189 | 185 | ||||||
| Finance Lease Right Of Use Asset | 24 | 25 | 26 | 27 | 28 | 27 | 28 | 29 | 29 | 30 | 31 | 31 | ||||||
| Intangible Assets Net Excluding Goodwill | 6 | 6 | 6 | 6 | 7 | 6 | 7 | 7 | 7 | 68 | 71 | 73 | ||||||
| Goodwill | 167 | 167 | 167 | 167 | 167 | 166 | 166 | 166 | 166 | 166 | 166 | 166 | ||||||
| Deferred Income Tax Assets Net | 79 | 80 | 79 | 94 | 109 | 102 | 100 | 106 | 109 | 85 | 85 | 64 | ||||||
| Other Assets Noncurrent | 41 | 41 | 41 | 40 | 40 | 44 | 41 | 39 | 39 | 34 | 26 | 15 | ||||||
| Assets | 1,975 | 1,898 | 1,827 | 1,744 | 1,675 | 1,593 | 1,533 | 1,479 | 1,535 | 1,580 | 1,556 | 1,468 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 45 | 44 | 35 | 30 | 28 | 31 | 31 | 33 | 33 | 32 | 27 | 28 | ||||||
| Accrued Liabilities Current | 172 | 152 | 132 | 124 | 114 | 113 | 112 | 106 | 104 | 107 | 111 | 104 | ||||||
| Operating Lease Liability Current | 14 | 14 | 14 | 13 | 13 | 13 | 12 | 12 | 12 | 12 | 11 | 11 | ||||||
| Finance Lease Liability Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Liabilities Current | 234 | 212 | 183 | 170 | 158 | 159 | 158 | 153 | 151 | 153 | 151 | 145 | ||||||
| Operating Lease Liability Noncurrent | 176 | 179 | 183 | 180 | 183 | 185 | 187 | 190 | 192 | 195 | 197 | 192 | ||||||
| Finance Lease Liability Noncurrent | 20 | 20 | 21 | 21 | 22 | 21 | 22 | 22 | 23 | 23 | 24 | 24 | ||||||
| Other Liabilities Noncurrent | 14 | 13 | 12 | 15 | 18 | 16 | 15 | 9 | 8 | 6 | 5 | 3 | ||||||
| Liabilities | 444 | 425 | 399 | 386 | 381 | 380 | 382 | 375 | 373 | 376 | 377 | 364 | ||||||
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | ||||||||||||||||||
| Preferred Stock Value | - | - | 0 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 1,224 | 1,201 | 1,186 | 1,165 | 1,146 | 1,117 | 1,097 | 1,079 | 1,081 | 1,062 | 1,047 | 1,031 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 1 | 2 | 4 | 3 | 3 | -3 | -6 | -1 | -5 | -5 | -3 | -7 | ||||||
| Retained Earnings Accumulated Deficit | 305 | 270 | 238 | 190 | 144 | 99 | 60 | 26 | 86 | 146 | 135 | 81 | ||||||
| Stockholders Equity | 1,531 | 1,474 | 1,428 | 1,359 | 1,294 | 1,213 | 1,151 | 1,104 | 1,161 | 1,204 | 1,179 | 1,104 | ||||||
| Liabilities And Stockholders Equity | 1,975 | 1,898 | 1,827 | 1,744 | 1,675 | 1,593 | 1,533 | 1,479 | 1,535 | 1,580 | 1,556 | 1,468 | ||||||
| Allowance For Doubtful Accounts Receivable Current | - | - | 2 | - | - | - | 6 | - | - | - | 3 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | 0.00 | - | - | - | 0.00 | - | - | - | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | - | - | 5 | - | - | - | 5 | - | - | - | 5 | - | ||||||
| Preferred Stock Shares Issued | - | - | 0 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Preferred Stock Shares Outstanding | - | - | 0 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | - | - | 0.00 | - | - | - | 0.00 | - | - | - | 0.00 | - | ||||||
| Common Stock Shares Authorized | - | - | 300 | - | - | - | 300 | - | - | - | 300 | - | ||||||
| Common Stock Shares Issued | - | - | 39 | - | - | - | 38 | - | - | - | 39 | - | ||||||
| Shares Outstanding | - | - | 39 | - | - | - | 38 | - | - | - | 39 | - | ||||||
| Allowance For Doubtful Accounts Receivable | 2 | 2 | - | 2 | 6 | 6 | - | 3 | 3 | 3 | - | 3 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPenumbra Inc (PEN) — SEC Financial Statements & Analysis
Penumbra Inc (PEN) is a surgical & medical instruments & apparatus company, incorporated in DE. Penumbra Inc trades on NYSE as: PEN. Penumbra Inc (PEN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30. Based on that filing, Penumbra Inc carries a market cap of $12.43B, a P/E ratio of 77.38x, a P/B ratio of 8.12x, a P/S ratio of 8.26x, an enterprise value of $12.24B, and an EV/EBITDA multiple of 59.87x. On profitability, it posts a gross margin of 67.84%, an operating margin of 12.45%, a net margin of 10.67%, a Return on Equity (ROE) of 11.37%, a Return on Assets (ROA) of 8.80%, and a Return on Invested Capital (ROIC) of 12.84%. Per share, it reports EPS of $4.08, diluted EPS of $4.06, free cash flow per share of $5.49, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 17.55% year-over-year, net income growth of 8.72% year-over-year, and EPS growth of 7.29% year-over-year. On the balance sheet, it maintains a current ratio of 5.75x, a quick ratio of 3.63x, working capital of $1.11B, a debt-to-equity ratio of 0.29x, a debt ratio of 0.22, an interest coverage ratio of -18.88x, free cash flow of $215.91M (TTM), and net debt of $-183.26M. Figures sourced from SEC EDGAR.
- Market Cap
- $12.43B
- P/E TTM
- 77.38x
- EPS TTM
- $4.08
- P/B TTM
- 8.12x
- ROE TTM
- 11.37%
- ROA TTM
- 8.80%
- Debt To Equity
- 0.29x
- Free Cash Flow TTM
- $215.91M
- Net Revenue TTM Growth 1Y
- 17.55%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Penumbra Inc in?
Penumbra Inc (PEN) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does PEN trade on?
Penumbra Inc (PEN) trades on the NYSE.
Where is Penumbra Inc incorporated?
Penumbra Inc is incorporated in DE.
When was Penumbra Inc (PEN)'s most recent SEC filing?
Penumbra Inc (PEN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30.
What is PEN's market cap?
Penumbra Inc (PEN) has a market capitalization of $12.43B as of 2026-06-30.
What is PEN's P/E ratio?
Penumbra Inc (PEN)'s trailing twelve month P/E ratio is 77.38x as of 2026-06-30.
What is PEN's EPS (earnings per share)?
Penumbra Inc (PEN)'s trailing twelve month EPS is $4.08 as of 2026-06-30.
What is PEN's ROE (return on equity)?
Penumbra Inc (PEN)'s trailing twelve month Return on Equity (ROE) is 11.37% as of 2026-06-30.
What is PEN's ROA (return on assets)?
Penumbra Inc (PEN)'s trailing twelve month Return on Assets (ROA) is 8.80% as of 2026-06-30.
What is PEN's ROIC (return on invested capital)?
Penumbra Inc (PEN)'s trailing twelve month Return on Invested Capital (ROIC) is 12.84% as of 2026-06-30.
What is PEN's EV/EBITDA?
Penumbra Inc (PEN)'s trailing twelve month EV/EBITDA is 59.87x as of 2026-06-30.